Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
81 hedge funds and large institutions have $8.82M invested in Ampio Pharmaceuticals Inc. in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 4 reducing their positions, and 15 closing their positions.
775% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 4
467% more call options, than puts
Call options by funds: $261K | Put options by funds: $46K
6% less funds holding
Funds holding: 86 → 81 (-5)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
77% less capital invested
Capital invested by funds: $38.5M → $8.82M (-$29.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$604K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$584K |
| 3 |
CC
Courier Capital
Buffalo,
New York
|
+$405K |
| 4 |
State Street
Boston,
Massachusetts
|
+$331K |
| 5 |
BlackRock
New York
|
+$325K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$5.71M |
| 2 |
NFG
Noven Financial Group
Denver,
Colorado
|
-$229K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$134K |
| 4 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
-$110K |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$101K |
AMPE Hedge Fund Activity: Q3 2018 in Review
81 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2018, worth a combined $8.82M — down 77% from $38.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AMPE and 10 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 35 added.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $604K. The largest seller was Knoll Capital Management, exiting entirely with an estimated $5.71M sold.
- 81 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2018, down from 86 in Q2 2018.
- Funds reported $8.82M of Ampio Pharmaceuticals Inc. stock for Q3 2018, down 77% quarter-over-quarter.
- 10 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2018 and 15 closed out, a net change of -5 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2018 was Russell Investments Group, an estimated $604K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2018 was Knoll Capital Management, an estimated $5.71M sold.
Based on aggregated 13F filings for Q3 2018.